Alliance for Cancer Gene Therapy
@ACGTFoundation
Followers
2K
Following
728
Media
492
Statuses
3K
ACGT funds innovative scientists working to harness the power of cell and gene therapy to transform how cancer is treated and to drive momentum toward a cure.
Stamford, CT
Joined March 2010
Sign up today to receive ACGT’s monthly e-newsletter, highlighting the latest developments in cell and gene therapy for cancer:
acgtfoundation.org
Join our Alliance and help fund cancer cell and gene therapy. You can receive information on updates in the field.
0
0
0
A practicing radiologist, Robyn Stacy-Humphries, MD survived a difficult bout with lymphoma through cell and gene therapy. Now, she’s using her story to lead and inspire others facing similar battles. Read more about Dr. Stacy-Humphries’ inspiring story:
acgtfoundation.org
For Robyn Stacy-Humphries, MD, diagnosing cancer was her day job. So, when the practicing radiologist in North Carolina felt a lump in her neck that should not have been there, she knew what she was...
0
0
0
RT @RallyForNIH: We are grateful to our partners for their support of #RallyMedRes, Sept 17-18. Thank you for working with us in support of….
0
3
0
Earlier this year Ben Stanger, MD, received ACGT's Edward Netter Memorial Investigator Award in Cell and Gene Therapy Research for Pancreatic Cancer for his study into a new approach to treat pancreatic cancer. Read more here:
acgtfoundation.org
Pancreatic cancer is the third leading cause of cancer death in the United States and is trending to move into second place within the next several years. Despite that, the options available to treat...
0
0
1
Philip Greenberg, MD recently received a $500,000 grant co-funded by ACGT and @TheMarkFdn, supporting his research into inserting genes into T cells that can coordinate a response against tumor cells. Read more about Dr. Greenberg’s research here:
acgtfoundation.org
While considerable effort has been expended in researching effective treatments, a pancreatic cancer diagnosis is still greatly challenging for both patients and their physicians with 5-year survival...
0
2
7
This month for National Cancer Survivors Month, ACGT recognizes brave cancer patients and survivors who have undergone or are undergoing cell and gene therapy. Now, we want to help you tell your story. Please email David Statman at dstatman@acgtfoundation.org.
0
0
1
RT @MucosalMelanoma: Supporting #CancerResearch & #ClinicalTrial funding W/ @ACGTFoundation with @SAA_Inc in Stamford CT. #MucosalMelanomaS….
0
2
0
The ACGT – Edward Netter Memorial Investigator Award in Cell and Gene Therapy Research for Pancreatic Cancer has been awarded to a collaboration between Ben Z. Stanger, MD, PhD and Carl June, MD. Read more:
acgtfoundation.org
Ben Z. Stanger, MD, PhD, and Carl June, MD, of the University of Pennsylvania receive three-year research grant from ACGT. STAMFORD, Conn., May 19, 2025 — A $500,000 grant from Alliance for Cancer...
0
0
1
Cell and gene therapies are helping cancer patients become cancer survivors. Read about some of these survivor stories on ACGT’s website: #NationalCancerSurvivorsMonth.
acgtfoundation.org
Stories of patients beating cancer thanks to receiving cell and gene therapies demonstrate the potential of this science to lead to cures.
0
0
3
Congratulations to ACGT Board member Bruce Levine, and ACGT SAC members, Carl June, Michel Sadelain, and Isabelle Riviere for receiving the 2025 Richard N. Merkin Prize in Biomedical Technology for their roles in developing CAR T cell therapy! Read more:
broadinstitute.org
The winners are Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain, who developed technology that reprograms patients’ immune systems to target cancer, leading to several FDA-approved...
0
0
4
RT @Jun_kiim: NG34C, A Novel Oncolytic Virus Expressing Truncated GADD34 Gene for Glioblastoma. “What makes funding from ACGT impactful is….
0
1
0
Scientists,.There’s only one day left to submit a pre-application Letter of Intent for our 2025 Investigator Awards in Cell and Gene Therapy for Gynecological Research and Breast Cancer. Visit the ACGT website for full details:
acgtfoundation.org
Alliance for Cancer Gene Therapy often issues Request for Applications for researchers seeking funding in cell and gene therapy.
0
0
3
RT @golabnow: Recently, our director Dr. Sanaz Memarzadeh was a panelist at the Alliance for Cancer Gene Therapy @ACGTFoundation Summit. Sh….
0
1
0
ALERT: ACGT has two open Requests for Applications for cancer cell and gene therapy research with LOIs due next week! Our focus this year is on women's cancers - learn more on our website:.
acgtfoundation.org
Alliance for Cancer Gene Therapy often issues Request for Applications for researchers seeking funding in cell and gene therapy.
0
0
3
ACGT is now accepting applications for the 2025 Investigator Awards in Cell and Gene Therapy for Gynecological Research, as well as in Breast Cancer. The Letter of Intent deadline is May 16. Visit our website for more details:
acgtfoundation.org
Alliance for Cancer Gene Therapy often issues Request for Applications for researchers seeking funding in cell and gene therapy.
0
1
2
If you, or someone you know, has received cell and gene therapy for cancer and is in remission please share your experience with us. Survivor stories can inspire & empower others to learn more about cell and gene therapy. Please email David Statman at dstatman@acgtfoundation.org.
0
0
0
Last month, ACGT held its annual scientific summit – ACGT Summit 2025 – an invitation-only gathering bringing together top scientists in cancer cell and gene therapy. Read more about Summit 2025:
acgtfoundation.org
ACGT presented Summit 2025 in April. The annual, invitation-only event brought together top scientists in cancer cell and gene therapy.
0
0
4
Sign up today to receive ACGT’s monthly e-newsletter, highlighting the latest developments in cell and gene therapy for cancer:
acgtfoundation.org
Join our Alliance and help fund cancer cell and gene therapy. You can receive information on updates in the field.
0
0
0
New CAR T-Cell Therapy Approved for Leukemia - The FDA has approved AUCATZYL® (obecabtagene autoleucel – obe-cel) for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
autolus.gcs-web.com
AUCATZYL is the first CAR T therapy approved by the FDA with no requirement for a REMS program (Risk Evaluation Mitigation Strategy) Approval based on FELIX clinical trial of obe-cel in adult...
0
0
1
If you are attending @SITCcancer #SITC2024 but missed today's TIL Symposium, join ACGT on Friday and hear from Shari Pilon Thomas @MoffittNews and @GeorgeCoukos on the future of TIL therapy! Registration link is below - a few seats left so don't wait!.
0
0
1